Deposition, retention and translocation of ultrafine carbonaceous particles from central and peripheral lung regions in healthy subjects and in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 459s Year: 2006
Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
Comparison of aerosol deposition pattern in healthy vs. asthmatic subjects Source: Annual Congress 2012 - Different ways to phenotype asthma Year: 2012
Association between sputum inflammatory markers and carbon loading of alveolar macrophages in healthy children Source: Eur Respir J 2005; 26: Suppl. 49, 385s Year: 2005
Comparison of cytotoxic markers expression on the surface of lymphocytes in BAL fluid and peripheral blood samples from patients with pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 322s Year: 2004
Cellular and structural changes in peripheral airways of subjects with severe COPD Source: Eur Respir J 2001; 18: Suppl. 33, 91s Year: 2001
Measurement of lung distensibility in healthy children Source: International Congress 2017 – Lung function practice in daily life Year: 2017
Reduction of particles by using a particle separator in pig barn environment reduces inflammatory response in healthy volunteers Source: Annual Congress 2012 - Respiratory diseases at at work: epidemiology, inflammation and challenge studies Year: 2012
Increased deposition of activated complement in peripheral lung vessels of smokers Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010
Calculation of peripheral airspace dimensions from deposition of inhaled nanoparticles Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016
Effect of ultrafine particle matter on human peripheral blood mononuclear cells of chronic obstructive pulmonary disease patients: involvement of the inflammasome. Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017
Quantitative biokinetics of gold nanoparticles (NP) between 1.4 and 200 nm administered either to the lungs, blood or gut of rats Source: Annual Congress 2008 - COPD and other environment-related lung diseases Year: 2008
Expansion of alveolar-lymphoid interfaces in lungs of patients with COPD Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012
Controlled inhalation improves total and peripheral lung deposition in CF Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019
Biomarkers in peripheral blood from patients with chronic silicosis caused by artificial quartz agglomerates Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019
Quantification of inflammatory cytokines in exhaled breath particles following segmental and inhalation endotoxin challenge of healthy volunteers Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021
Alteration in blood cellular populations in patients with chronic silicosis caused by artificial quartz agglomerates Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation Year: 2018
Effect of particle size of dry powder mannitol on lung deposition in healthy subjects Source: Eur Respir J 2006; 28: Suppl. 50, 434s Year: 2006
Alveolar fraction of exhaled NO (Calv) in patients with heart failure is higher than in asthmatic and normal subjects Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008
Oral NO contribution affects the estimated alveolar NO concentration in healthy volunteers Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006